Ma. Mansoor et al., REDOX STATUS AND PROTEIN-BINDING OF PLASMA AMINOTHIOLS DURING THE TRANSIENT HYPERHOMOCYSTEINEMIA THAT FOLLOWS HOMOCYSTEINE ADMINISTRATION, Clinical chemistry, 39(6), 1993, pp. 980-985
We administered reduced L-homocysteine perorally (67 mumol/kg of body
wt) to 12 healthy subjects and injected the same dose into one person,
and determined the kinetics of the alterations in reduced, oxidized,
and protein-bound concentrations of homocysteine, cysteine, and cystei
nylglycine. After oral intake, reduced homocysteine increased rapidly
(t(max) less-than-or-equal-to 15 min), reaching concentrations [3.97 (
SD 2.99) mumol/L] 20-fold above fasting values, and then declined towa
rds the normal concentration within 2 h. There was a similar increase
in reduced cysteine and a moderate increase in reduced cysteinylglycin
e. During this response, we observed a positive correlation between th
e reduced/total ratio for homocysteine and cysteine. When homocysteine
was injected, the increase in reduced homocysteine preceded the incre
ase in reduced cysteine by about 3 min. After oral loading, oxidized h
omocysteine showed a transient increase (t(max) = 30 min) that lagged
behind the increase of reduced homocysteine. Oxidized cysteine and cys
teinylglycine were stable or decreased slightly. Protein-bound homocys
teine increased the least rapidly after homocysteine administration (t
(max) = 1-2 h), and returned to normal values slowly. Changes in prote
in-bound homocysteine essentially mirrored a concurrent decrease in pr
otein-bound cysteine, suggesting displacement of bound cysteine. These
data show that plasma homocysteine has a pronounced, direct effect on
the redox status and protein binding of other plasma thiol components
. Such effects should be recognized when studying the mechanisms behin
d the atherogenic effect of increased plasma homocysteine.